HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

QLT 0267

inhibits both FMS-like tyrosine kinase 3 (FLT3) and integrin linked kinase (ILK); structure in first source
Also Known As:
QLT-0267; QLT0267
Networked: 12 relevant articles (3 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bally, Marcel B: 4 articles (09/2015 - 01/2006)
2. Kalra, Jessica: 4 articles (09/2015 - 01/2008)
3. Dedhar, Shoukat: 4 articles (01/2009 - 01/2006)
4. Mills, Gordon B: 3 articles (01/2007 - 08/2005)
5. Waterhouse, Dawn: 2 articles (05/2011 - 01/2009)
6. Yan, Hong: 2 articles (05/2011 - 01/2008)
7. Warburton, Corinna: 2 articles (05/2011 - 01/2009)
8. Daynard, Tim: 2 articles (01/2009 - 01/2008)
9. Jasser, Samar A: 2 articles (01/2007 - 08/2005)
10. Dunn, Sandra E: 2 articles (01/2007 - 01/2006)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Sarcoma (Soft Tissue Sarcoma)
4. Squamous Cell Carcinoma (Epidermoid Carcinoma)
5. Disease Progression

Related Drugs and Biologics

1. integrin-linked kinase
2. squamous cell of head and neck Carcinoma
3. docetaxel (Taxotere)
4. Actins (F Actin)
5. Sirolimus (Rapamycin)
6. Phosphotransferases (Kinase)
7. Caspase 3 (Caspase-3)
8. Glycogen Synthase Kinase 3
9. Messenger RNA (mRNA)
10. Luciferases

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)